Barclays PLC Sight Sciences, Inc. Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Barclays PLC holds 56,294 shares of SGHT stock, worth $165,504. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,294
Previous 50,300
11.92%
Holding current value
$165,504
Previous $317,000
35.33%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SGHT
# of Institutions
84Shares Held
22.4MCall Options Held
62.8KPut Options Held
900-
Kck Ltd. Tortola, D84.37MShares$12.9 Million21.26% of portfolio
-
Ubs Group Ag2.35MShares$6.89 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR2.24MShares$6.58 Million0.28% of portfolio
-
Black Rock Inc. New York, NY2.12MShares$6.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$4.8 Million0.0% of portfolio
About Sight Sciences, Inc.
- Ticker SGHT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,826,200
- Market Cap $141M
- Description
- Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...